Perillyl Alcohol in Treating Patients With Refractory Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Phase I trial to study the effectiveness of perillyl alcohol in treating patients with
refractory cancer. Drugs used in chemotherapy use different ways to stop tumor cells from
dividing so they stop growing or die.